Evidence map›Paper›PMID 42778871›Full record

ArticleAcademic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry2026

A Multi-Site Evaluation of a Psychedelic Medicine Curriculum for Psychiatry Trainees.

Mary E Yaden, Kelley C O'Donnell, Daniel E Roberts, Noam Goldway, Praachi Tiwari, Terence H W Ching, Jamila Hokanson, Natalie Gukasyan, Brendan Appold, Giancarlo Glick and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mary E YadenJohns Hopkins University School of Medicine, Baltimore, MD, USA. Myaden1@jhmi.edu.ORCID http://orcid.org/0000-0002-4981-8335
Kelley C O'DonnellNYU Grossman School of Medicine, New York, NY, USA.
Daniel E RobertsNYU Grossman School of Medicine, New York, NY, USA.
Noam GoldwayKing's College London, London, UK.
Praachi TiwariJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Terence H W ChingYale University School of Medicine, New Haven, CT, USA.
Jamila HokansonYale University School of Medicine, New Haven, CT, USA.
Natalie GukasyanNew York State Psychiatric Institute, New York, NY, USA.
Brendan AppoldLarner College of Medicine at the University of Vermont, Burlington, VT, USA.
Giancarlo GlickStanford University School of Medicine, Stanford, CA, USA.
Benjamin KelmendiYale University School of Medicine, New Haven, CT, USA.
Stephen RossNYU Grossman School of Medicine, New York, NY, USA.
Christopher PittengerYale University School of Medicine, New Haven, CT, USA.

Funding

Heffter Research Institute 140289
6 · The paper itself

Abstract

objectiveInterest in psychedelic medicine is increasing, yet psychiatry trainees report limited education in this area. The authors developed a standardized curriculum and evaluated its impact on trainee knowledge and attitudes toward psychedelic medicines.

methodsA 6-h psychedelic medicine course was delivered across four psychiatry residency programs in the Northeast United States in 2025-2026. The curriculum included six modules covering foundational concepts and evidence, as well as clinical considerations. Anonymous pre- and post-course surveys assessed knowledge, interest, and confidence in counseling. Statistical comparisons were used to evaluate pre-post changes.

resultsForty trainees participated across institutions; 34 completed a pre-course survey and 22 completed a post-course survey. Most trainees reported minimal prior didactic exposure to psychedelic medicine. Self-assessed knowledge as well as scores on a knowledge quiz improved significantly following the course. Self-rated understanding of both the rationale for psychedelic treatments and limitations of evidence increased. Most substantially, confidence in counseling patients about clinical research, harm reduction, and treatment risks improved across domains. Baseline interest in psychedelic medicine was high at the start of the course and did not change significantly following its completion.

conclusionsA multi-site curriculum in psychedelic medicine was associated with increased knowledge and counseling confidence in trainees. The curriculum did not significantly impact interest or plans to pursue opportunities in psychedelic medicine, suggesting the course did not overinflate enthusiasm for the field. Standardized curricula in residency education may help address gaps in psychiatric training as clinicians increasingly encounter questions about these emerging treatments.

Indexed as

CurriculumGraduate medical educationMedical educationPsychedelic medicinePsychiatry residents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.